1 Both medications are licensed in the UK for type 2 diabetes only
8 Societal changes driven by uptake of GLP-1 weight loss medications The sweeping changes in food preference and appetite brought on by GLP-1RA pharmacotherapies are producing extensive downstream effects that reach beyond the individual, shaping broader cultural, social, and economic landscapes
Unlike many weight loss supplements, this stack takes a holistic approach, addressing hunger control, metabolism, gut health, and sleep
Clinical trials show comparable weight loss outcomes across all approved injection sites (abdomen, thigh, upper arm) when patients follow the same dosing schedule and maintain proper injection technique
Choosing the wrong source can mean sub-potent vials, inconsistent patient outcomes, and even safety risks